The effect of losigamone (AO-33) on electrical activity and excitatory amino acid release in mouse cortical slices

British Journal of Pharmacology

Volumn 122, Issue 7, 1997, Pages 1490-1494

  Srinivasan, Jayashri ^a   Richens, Alan ^a   Davies, John A ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

AMPA; Cortical slices; Epilepsy; Glutamate; Losigamone; NMDA

Indexed keywords

ANTICONVULSIVE AGENT; EXCITATORY AMINO ACID; GLUTAMIC ACID; LOSIGAMONE; POTASSIUM; VERATRIDINE;

ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN SLICE; ELECTRIC ACTIVITY; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0030833897     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0701539     Document Type: Article

References (24)

1. ABILA, B., RICHENS, A. & DAVIES, J.A. (1993). Anticonvulsant effects of extracts of the West African black pepper, Piper guineense. J. Ethnopharmacol., 39, 113-117.
2. ARAM, J.A., MARTIN, D., TOMCZYK, M., MILLAR, J., POHLER, G. & LODGE, D. (1989). Neocortical epileptogenesis in vitro: studies with NMDA, PCP, sigma and dextromethorphan receptor ligands. J. Pharmacol. Exp. Ther., 248, 320-328.
3. DICKIE, B.G.M., ANNELS, S.J. & DAVIES, J.A. (1994). Effects of cyclooxygenase inhibition upon glutamate release from rat cerebellum. NeuroReport, 5, 393-396.
4. DICKIE, B.G.M. & DAVIES, J.A. (1992). Calcium blocking agents and potassium-stimulated release of glutamate from cerebellar slices. Eur. J. Pharmacol., 229, 97-99.
5. A receptor system. Epilepsia, 36, 983-989.
6. HORNE, A.L., HARRISON, N.L., TURNER, J.P. & SIMMONDS, M.A. (1986). Spontaneous paroxysmal activity induced by zero magnesium and bicuculline: suppression by NMDA antagonists and GABA mimetics. Eur. J. Pharmacol., 122, 231-238.
7. HU, R.Q. & DAVIES, J.A. (1995). The effect of the desglycinyl metabolite of remacemide on cortical wedges prepared from DBA/2 mice. Eur. J. Pharmacol., 287, 251-256.
8. HUNTLEY, G.W., VICKERS, J.C. & MORRISON, J.H. (1994). Cellular and synaptic localization of NMDA and non-NMDA receptor subunits in neocortex: organizational features related to cortical circuitry, function and disease. Trends Neurosci., 17, 536-543.
9. JOBE, P., MISHRA, P., LUIG, N. & DAILEY, W. (1991). Sope and contribution of genetic models to an understanding of epilepsy. Neurobiology, 6, 183-220.
10. KAPTENOVIC, I.M., YONEKAWA, W. & KUPFERBERG, H.J. (1995). The effects of anticonvulsant compounds on 4-aminopyridine-induced de novo synthesis of neurotransmitter amino acids in rat hippocampus in vitro. Epilepsy Res., 20, 113-120.
11. KOHR, G. & HEINEMANN, U. (1990a). Effects of tetronic acid derivatives AO-33 (losigamone) and AO-78 on epileptiform activity in rat hippocampal slices. Epilepsy Res., 7, 49-55.
12. KOHR, G. & HEINEMANN, U. (1990b). Anticonvulsant properties of tetronic acid derivatives on picrotoxin-induced epileptiform activity in rat hippocampal slices. Neurosci. Lett., 112, 43-47.
13. LEACH, M.J., MARDEN, C.M. & MILLER, A.A. (1986). Pharmacological studies on lamotrigine, a novel potential antiepileptic drug: II. Neurochemical studies on the mechanism of action. Epilepsia, 27, 490-497.
14. 2+ concentration. Exp. Brain Res., 96, 230-240.
15. LEVI, G., GALLO, V. & RAITERI, M. (1980). A re-evaluation of veratridine as a tool for studying the depolarisation-induced release of neurotransmitter from nerve-endings. Neurochem. Res., 5, 281-295.
16. MELDRUM, B.S. (1992). Excitatory amino acids in epilepsy and potential novel therapies. Epilepsy Res., 12, 189-196.
17. MINCHIN, M.C.W. (1980). Veratrum alkaloids as transmitter-releasing agents. J. Neurosci. Meth., 2, 111-112.
18. MONTAGUE, P.R., GANCAYCO, C.D., WINN, M.J., MARCHASE, R.B. & FRIEDLANDER, M.J. (1994). Role of NO production in NMDA receptor-mediated neurotransmitter release in cerebral cortex. Science, 263, 973-977.
19. PALMER, A.J., ZEMAN, S. & LODGE, D. (1992). Methohexitone antagonises kainate and epileptiform activity in rat neocortical slices. Eur. J. Pharmacol., 221, 205-209.
20. ROWLEY, H.L., ELLIS, Y. & DAVIES, J.A. (1993). Age-related effects of NMDA-stimulated concomitant release of nitric oxide and glutamate in cortical slices prepared from DBA/2 mice. Brain Res., 613, 49-53.
21. SCHMITZ, D., GLOVELLI, T. & HEINEMANN, U. (1995). Effect of losigamone on synaptic potentials and spike frequency habituation in rat entorhinal cortex and hippocampal CA1 neurones. Neurosci. Lett., 200, 141-143.
22. SRINIVASAN, J., RICHENS, A. & DAVIES, J.A. (1995). The effect of the desglycinyl metabolite of remacemide hydrochloride (FPL 12495AA) and dizocilpine (MK-801) on endogenous amino acid release from mouse cortex. Br. J. Pharmacol., 116, 3087-3092.
23. STEIN, U. (1995). Losigamone. In Antiepileptic Drugs, ed. Levy, R., Mattson, R. & Meldrum, B. pp. 1025-1034. New York: Raven Press.
24. YONEKAWA, W.D., KAPETANOVIC, I.M. & KUPFERBERG, H.J. (1995). The activity in rat hippocampus in vitro. Epilepsy Res., 20, 137-150.